World's Best Scientists 2026 revealed!
Claudio Viscoli

Claudio Viscoli

D-Index & Metrics

Microbiology

D-Index
91
Citations
39633
World Ranking
638
National Ranking
14

Medicine

D-Index
92
Citations
40645
World Ranking
11130
National Ranking
405

Claudio Viscoli publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Claudio Viscoli sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 438 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Claudio Viscoli D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio Viscoli sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 91 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Claudio Viscoli was affiliated with the University of Genoa in Italy and contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research spanned several subfields, including infectious diseases, epidemiology, molecular medicine, pharmacology, and applied microbiology and biotechnology.

Their scientific work focused on topics related to antibiotic resistance in bacteria, antifungal resistance and susceptibility, antibiotic pharmacokinetics and efficacy, antibiotic use and resistance, antimicrobial resistance in Staphylococcus species, infections and bacterial resistance, and Pneumocystis jirovecii pneumonia detection and treatment.

Viscoli authored multiple papers covering a range of issues within infectious diseases and antimicrobial resistance. Notable recent papers included:

  • Pneumocystis jiroveciiDisease: Basis for the Revised EORTC/MSGERC Invasive Fungal Disease Definitions in Individuals Without Human Immunodeficiency Virus, 2020, Clinical Infectious Diseases
  • Changing epidemiology of candidaemia: Increase in fluconazole-resistant Candida parapsilosis, 2020, Mycoses
  • Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study), 2020, Open Forum Infectious Diseases
  • Changes in the relative prevalence of candidaemia due to non-albicans Candida species in adult in-patients: A systematic review, meta-analysis and meta-regression, 2020, Mycoses
  • Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA), 2023, EClinicalMedicine

Their frequent coauthors included Daniele Roberto Giacobbe, Matteo Bassetti, Pierluigi Viale, Anna Marchese, and Maddalena Giannella, indicating collaboration within a focused network of infectious disease and microbiology experts.

Viscoli published frequently in venues such as Mycoses, Clinical Infectious Diseases, Open Forum Infectious Diseases, EClinicalMedicine, and Clinical Microbiology and Infection, reflecting their contributions to clinical and microbiological research communities.

Best Publications

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

    O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy

    Mario Tumbarello;Pierluigi Viale;Claudio Viscoli;Enrico Maria Trecarichi

  • Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

    C. Viscoli;C. Girmenia;A. Marinus;L. Collette

  • ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

    Frederic Tissot;Samir G. Agrawal;Livio Pagano;Georgios Petrikkos

  • European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

    Diana Averbuch;Christina Orasch;Catherine Cordonnier;David M. Livermore

  • Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

    B J Kullberg;J D Sobel;M Ruhnke;P G Pappas

  • Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study

    Mario Tumbarello;Enrico Maria Trecarichi;Francesco Giuseppe De Rosa;Maddalena Giannella

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

    Emanuele Durante-Mangoni;Giuseppe Signoriello;Roberto Andini;Annunziata Mattei

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012:diagnostic procedures

    M. Cuenca-Estrella;P. E Verweij;M. C Arendrup;S. Arikan-Akdagli

  • Epidemiological trends in nosocomial candidemia in intensive care.

    Matteo Bassetti;Elda Righi;Alessandro Nanni Costa;Roberta Fasce

  • ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp

    W.W. Hope;E. Castagnola;A.H. Groll;E. Roilides

  • ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

    A.J. Ullmann;M. Akova;R. Herbrecht;C. Viscoli

  • The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.

    Malgorzata Karolina Mikulska;Thierry Calandra;Maurizio Sanguinetti;Daniel Poulain

  • A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies

    Ian Hann;Claudio Viscoli;Marianne Paesmans;Harold Gaya

  • International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

    J E Jr Edwards;G. P. Bodey;R. A. Bowden;T. Buchner

Frequent Co-Authors

Matteo Bassetti
Matteo Bassetti University of Genoa
Giancarlo Icardi
Giancarlo Icardi University of Genoa
Pierluigi Viale
Pierluigi Viale University of Bologna
Mario Tumbarello
Mario Tumbarello Catholic University of the Sacred Heart
Elda Righi
Elda Righi University of Verona
Anna Marchese
Anna Marchese University of Genoa
Mauro Giacomini
Mauro Giacomini McMaster University
Raoul Herbrecht
Raoul Herbrecht University of Strasbourg
Roberto Cauda
Roberto Cauda Catholic University of the Sacred Heart
Maurizio Sanguinetti
Maurizio Sanguinetti Catholic University of the Sacred Heart

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens up diverse career opportunities, especially when complemented with related online programs. For those interested in the intersection of healthcare and data management, exploring online health information management programs cahiim accredited offers a reputable pathway to gain essential skills in managing medical records and healthcare data securely.

If you prefer a more focused, skill-based approach, accelerated options like the accelerated medical billing and coding certificate online provide a fast track to certification, equipping students with crucial billing expertise for medical environments.

For broader healthcare career paths, various online healthcare programs expand your qualifications, offering flexible learning that fits busy schedules while keeping you competitive in a growing job market.

Additionally, those interested in public health can consider online public health masters programs easy to get into, which provide accessible options to deepen your impact in community health, epidemiology, and health policy.

Best Scientists Citing Claudio Viscoli

Recently Published Articles